OneOncology said it will embed OpenEvidence’s medical AI chatbot and search engine into community oncology clinics to assist with decision-making and literature navigation. OpenEvidence’s platform is designed to support workups, compute formulas, generate prior authorization letters, and recommend tests, with an emphasis on oncology-specific training. The integration includes plans to connect the AI tool with OneOncology’s genomic and clinical trial matching databases built partly through partnerships with Genentech and Foundation Medicine. OpenEvidence also positions its product as HIPAA compliant and notes that it became unavailable in Europe earlier due to regulatory uncertainty around the EU AI Act. For biopharma and companion diagnostic stakeholders, this matters because workflow adoption can accelerate biomarker-driven treatment selection and trial matching—areas where data access and timeliness influence enrollment and outcomes.